GPT-Rosalind, a new OpenAI tool based on GPT-4 and fine-tuned on scientific data, has been launched to accelerate life sciences research. It addresses the data bottleneck by optimizing hypothesis generation, literature analysis, and experimental design, with the potential to reduce drug development costs and timelines.
The article questions the reality of Colossal Biosciences' claim of cloning red wolves. It begins with a scene-setting description of a morning drive with two young scientists.
Biologists are using Co-Scientist to find novel factors that successfully rejuvenate human cells, fast-tracking research into cellular aging.
This edition of The Download explores the technological advancements transforming IVF, making it less painful and more accessible. It also highlights the emergence of balcony solar solutions.
Co-Scientist is facilitating a collaboration between Boston Children’s Hospital and MIT to investigate novel RNA-based therapies for Amyotrophic Lateral Sclerosis (ALS). This initiative aims to develop new treatment approaches by combining their biological toolkits.
Today's edition of The Download features news on Colossal Biosciences' groundbreaking work in growing chickens within 3D-printed artificial eggshells. This innovative approach sees chicks developing and attempting to hatch from engineered structures rather than natural eggs.
Technology has revolutionized babymaking, driven by the pioneering work that led to the first "test tube baby" in 1978. The author is exploring the cutting edge of IVF technologies and what's coming next.
This exclusive eBook explores R3 Bio, a startup that has pitched brainless human clones to serve as backup bodies. This startling and ethically charged vision aims to facilitate living forever.